Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 9, 2013, Pages 1312-1320

  Uchida, Takahiro ^a   Yoshida, Miyako ^a   Hazekawa, Mai ^a   Haraguchi, Tamami ^a   Furuno, Hiroyuki ^b   Teraoka, Makoto ^b   Ikezaki, Hidekazu ^c  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^b Higuchi Inc   (Japan)

^c Intelligent Sensor Technology   (Japan)

Author keywords

amlodipine; bitterness; disintegration method for orally disintegrating tablet; gustatory sensation test; taste sensor

Indexed keywords

AMLODINE OD; AMLODIPINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTIFICIAL TASTE SENSOR; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG SOLUBILITY; ELECTRONIC SENSOR; FACTORIAL ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORALLY DISINTEGRATING TABLET; PALATABILITY; PREDICTION; TABLET; TABLET FORMULATION; TASTE;

EID: 84881408832     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12101     Document Type: Article

References (28)

1. Naidu HR, et al. Stability indicating RPHPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product. J Pharm Biomed Anal 2005; 39: 147-155.
2. Bi Y, et al. Preparation and evaluation of a compress tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull 1996; 44: 2121-2127. (Pubitemid 26396765)
3. Makino T,. Expectations to orally disintegrating dosage forms collecting essences of pharmaceutical technology. Pharm Tech Jpn 2006; 22: 57-61.
4. Masuda Y,. The current and formulation design of fast oral-disintegrating tablets. Pharm Tech Jpn 2006; 22: 401-412.
5. Tsushima Y,. Prospect for oral disintegrating tablet. Pharm Tech Jpn 2009; 25: 1533-1542.
6. Narazaki R, et al. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull 2004; 52: 704-707. (Pubitemid 41685508)
7. Kashima A, et al. Evaluation of quality of orodispersible famotidine tablets. Jpn J Health Care Sci 2006; 32: 511-516.
8. Hashimoto Y, et al. The quantitative prediction of bitterness-suppressing effect of sweeteners on the bitterness of famotidine by sweetness-responsive sensor. Chem Pharm Bull 2007; 55: 739-746. (Pubitemid 46708599)
9. Tachiki H, et al. Bjtterness evaluation of famotidine orally disintegrating tablets using a taste sensor. Jpn J Med Pharm Sci 2005; 54: 321-327.
10. Tokuyama E, et al. Famotidine orally disintegrating tablets: bitterness comparison of original and generic products. Chem Pharm Bull 2009; 57: 382-387.
11. Mukai J, et al. Quantitive taste evaluation of total enternal nutrients. Chem Pharm Bull 2004; 52: 1416-1421. (Pubitemid 41364417)
12. Kataoka M, et al. Evaluation of bottled nutritive drinks using a taste sensor. Int J Pharm 2004; 279: 107-114. (Pubitemid 38968646)
13. ' European Pharmacopeia 6.0. 2008, p. 750.
14. Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry: orally disintegrating tablets. U.S. Department of Health and Human Services, USA, 2008.
15. Harada T, et al. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test. Chem Pharm Bull 2006; 54: 1072-1075. (Pubitemid 44166393)
16. Kakutani R, et al. Development of a new disintegration method for orally disintegrating tablets. Chem Pharm Bull 2009; 58: 885-890.
17. Uchida T, et al. Factors affecting the bitterness intensities of ten commercial formulations of ambroxol. Chem Pharm Bull 2012; 60: 949-954.
18. Hashimoto Y, et al. Preparation, characterization and taste-masking properties of polyvinylacetal diethylaminoacetate microspheres containing trimebutine. J Pharm Pharmacol 2002; 54: 1323-1328. (Pubitemid 35174176)
19. Akiyoshi T, et al. Effects of quinine on the intracellular calcium level and membrane potential of PC12. J Pharm Pharmacol 2007; 59: 1521-1526. (Pubitemid 350057455)
20. Uchida T, et al. Evaluation of the bitterness of antibiotics using a taste sensor. J Pharm Pharmacol 2003; 55: 1479-1485. (Pubitemid 37441353)
21. Miyanaga Y, et al. Suppression of the bitterness of enteral nutrients using increased particle sizes of Branched-Chain Amino Acids (BCAAs) and Various Flavours: a Taste Sensor Study. Chem Pharm Bull 2004; 52: 490-493. (Pubitemid 41694745)
22. Yoshida M, et al. Bitterness suppression of the Kampo Medicine 'Orengedokuto' Using Flavoured Jellies. Chem Pharm Bull 2010; 58: 449-453.
23. Ogawa T, et al. Screening of bitterness-suppressing agents for quinine: the use of molecularly imprinted polymers. J Pharm Sci 2005; 94: 353-362. (Pubitemid 40293331)
24. Harada T, et al. A new method for evaluating the bitterness of medicines in development using a taste sensor and a disintegration testing apparatus. Chem Pharm Bull 2010; 58: 1009-1014.
25. 1-receptor antagonists using a taste sensor. Sens Mater 2011; 23: 483-492.
26. Uchida T, et al. Factors affecting the bitterness intensities of ten commercial formulations of ambloxol. Chem Pharm Bull 2012; 60: 949-954.
27. Osgood CE, et al. The Measurement of Meaning. Urbana: University of Illinois Press, 1957.
28. Miyanaga Y, et al. Quantitative prediction of the bitterness suppression of elemental diets by various flavors using a taste sensor. Pharm Res 2003; 20: 1932-1938. (Pubitemid 38005523)